Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia.

Ng D, Toure O, Fontaine L, McMaster ML, Goldin LR, Caporaso N, Toro JR.

Br J Haematol. 2007 Apr;137(2):173-5. No abstract available.

PMID:
17391501
2.

Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia.

Sellick GS, Catovsky D, Houlston RS.

Leuk Res. 2006 Dec;30(12):1573-6. Epub 2006 Apr 3.

PMID:
16581122
3.

Familial cancer associated with a polymorphism in ARLTS1.

Sellick GS, Catovsky D, Houlston RS.

N Engl J Med. 2006 Mar 16;354(11):1204-5; author reply 1204-5. No abstract available.

4.

ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

Hamadou WS, Besbes S, Mani R, Bourdon V, Ben Youssef Y, Achour B, Regaieg H, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Sobol H, Soua Z.

Bull Cancer. 2017 Feb;104(2):123-127. doi: 10.1016/j.bulcan.2016.10.016. Epub 2016 Nov 17.

PMID:
27866680
5.

Association of the ARLTS1 variants with familial ovarian cancer risk in China.

Yang XY, Yu H, Xi MR, Yang KX, Pan XL, Hu M, Peng ZL.

Int J Gynecol Cancer. 2009 May;19(4):585-90. doi: 10.1111/IGC.0b013e3181a39d03.

PMID:
19509554
6.

ARLTS1 - a novel tumor suppressor gene.

Yendamuri S, Trapasso F, Calin GA.

Cancer Lett. 2008 Jun 8;264(1):11-20. doi: 10.1016/j.canlet.2008.02.021. Epub 2008 Mar 28. Review.

PMID:
18375053
7.

A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.

Pratt G, Fenton JA, Allsup D, Fegan C, Morgan GJ, Jackson G, Sunter NJ, Hall AG, Irving JA, Allan JM.

Br J Haematol. 2010 Aug;150(3):371-3. doi: 10.1111/j.1365-2141.2010.08199.x. Epub 2010 Apr 12. No abstract available.

PMID:
20408839
8.

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.

Siltanen S, Wahlfors T, Schindler M, Saramäki OR, Mpindi JP, Latonen L, Vessella RL, Tammela TL, Kallioniemi O, Visakorpi T, Schleutker J.

PLoS One. 2011;6(10):e26595. doi: 10.1371/journal.pone.0026595. Epub 2011 Oct 20.

9.

Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.

Frank B, Hemminki K, Meindl A, Wappenschmidt B, Klaes R, Schmutzler RK, Untch M, Bugert P, Bartram CR, Burwinkel B.

Int J Cancer. 2006 May 15;118(10):2505-8.

10.

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene.

Masojć B, Mierzejewski M, Cybulski C, van de Wetering T, Debniak T, Górski B, Jaworowska E, Tarnowska C, Lenner M, Scott RJ, Lubiński J.

Breast Cancer Res Treat. 2006 Sep;99(1):59-62. Epub 2006 Mar 29.

PMID:
16570116
11.

Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.

Castellví-Bel S, Castells A, de Cid R, Muñoz J, Balaguer F, Gonzalo V, Ruiz-Ponte C, Andreu M, Llor X, Jover R, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Carracedo A, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Carcinogenesis. 2007 Aug;28(8):1687-91. Epub 2007 Apr 21.

PMID:
17449901
12.

ARLTS1 and prostate cancer risk--analysis of expression and regulation.

Siltanen S, Fischer D, Rantapero T, Laitinen V, Mpindi JP, Kallioniemi O, Wahlfors T, Schleutker J.

PLoS One. 2013 Aug 5;8(8):e72040. doi: 10.1371/journal.pone.0072040. Print 2013.

13.

Familial cancer associated with a polymorphism in ARLTS1.

Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CM.

N Engl J Med. 2005 Apr 21;352(16):1667-76.

14.

Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia.

Dao-Ung LP, Fuller SJ, Sluyter R, SkarRatt KK, Thunberg U, Tobin G, Byth K, Ban M, Rosenquist R, Stewart GJ, Wiley JS.

Br J Haematol. 2004 Jun;125(6):815-7. No abstract available.

PMID:
15180873
15.

Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.

Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM.

Cancer Res. 2006 Nov 1;66(21):10287-91.

16.

ARLTS1 variants and risk of colorectal cancer.

Frank B, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B.

Cancer Lett. 2006 Dec 8;244(2):172-5. Epub 2006 Feb 20.

PMID:
16488076
17.

Familial cancer and ARLTS1.

De Brakeleer S, Teugels E, De Grève J.

N Engl J Med. 2005 Jul 21;353(3):313-4; author reply 313-4. No abstract available.

18.

ARLTS1 variants and melanoma risk.

Frank B, Meyer P, Boettger MB, Hemminki K, Stapelmann H, Gast A, Schmitt C, Kumar R, Sergi C, Burwinkel B.

Int J Cancer. 2006 Oct 1;119(7):1736-7.

19.

ARLTS1 Trp149Stop mutation and the risk of ovarian cancer.

Masojc B, Medrek K, Debniak T, Lubinski J, Wyrwicz LS, Koczyk G, Hoffmann M, Rychlewski L.

Cancer Res. 2007 May 1;67(9):4533; author reply 4534. No abstract available.

20.

Susceptibility genes and B-chronic lymphocytic leukaemia.

Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR.

Br J Haematol. 2007 Dec;139(5):762-71. Review.

PMID:
18021089

Supplemental Content

Support Center